Amferia breakthrough raises hope in superbug struggle

Swedish medtech company Amferia has announced findings showing that its peptide-based hydrogel could restore the effectiveness of antibiotics against resistant bacteria.

The results, achieved in collaboration with researchers at Chalmers University of Technology, reveal that combining antibiotics with Amferia’s proprietary material can enhance bactericidal effects by up to 64 times.

The innovative hydrogel, which incorporates antimicrobial peptides, reduced the required concentration of the antibiotic oxacillin to levels where it was effective against bacteria previously deemed resistant.